Rob Faulkner

Rob Faulkner began their work experience as a Managing Director at Redmile Group in February 2008. Since then, they have held various positions, including Chair of the Board at Science 37 starting in 2016, Chair of the Board at MedAvail Technologies Inc./MedAvail Technologies US Inc. starting in February 2020, and Board Member at Augmedix starting in April 2023. Additionally, Rob has served as a Board Member at Saluda Medical, Sphere Fluidics Limited, and Genalyte, Inc. Rob has also been a Board Observer at Impulse Dynamics, Employer Direct Healthcare, and Circadia Health.

Rob Faulkner has obtained an A.B. degree from Harvard University, a Master of Business Administration (M.B.A.) degree from The Tuck School of Business at Dartmouth, and a diploma from Belmont Hill School. No specific start or end years have been provided for any of these educational experiences.